-
1
-
-
0037129380
-
Nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD38XivVOmsrY%3D, PID: 11961152
-
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.
-
(2002)
N Engl J Med
, vol.346
, pp. 1221-1231
-
-
Angulo, P.1
-
2
-
-
69949085423
-
Non-alcoholic fatty liver disease
-
PID: 19608620
-
Bhala N, Usherwood T, George J. Non-alcoholic fatty liver disease. BMJ. 2009;339:b2474.
-
(2009)
BMJ
, vol.339
, pp. 2474
-
-
Bhala, N.1
Usherwood, T.2
George, J.3
-
3
-
-
84861543083
-
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
-
PID: 22488764
-
Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55:2005–23.
-
(2012)
Hepatology
, vol.55
, pp. 2005-2023
-
-
Chalasani, N.1
Younossi, Z.2
Lavine, J.E.3
-
4
-
-
22344452893
-
The natural history of nonalcoholic fatty liver disease: a population-based cohort study
-
PID: 16012941
-
Adams LA, Lymp JF, StSauver J, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129:113–21.
-
(2005)
Gastroenterology
, vol.129
, pp. 113-121
-
-
Adams, L.A.1
Lymp, J.F.2
StSauver, J.3
-
5
-
-
0043268063
-
Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C
-
PID: 12883486
-
Hui JM, Kench JG, Chitturi S, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003;38:420–7.
-
(2003)
Hepatology
, vol.38
, pp. 420-427
-
-
Hui, J.M.1
Kench, J.G.2
Chitturi, S.3
-
6
-
-
79955033727
-
Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma
-
PID: 21320639
-
Yasui K, Hashimoto E, Komorizono Y, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011;9:428–33.
-
(2011)
Clin Gastroenterol Hepatol.
, vol.9
, pp. 428-433
-
-
Yasui, K.1
Hashimoto, E.2
Komorizono, Y.3
-
7
-
-
79960549297
-
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
-
PID: 21688282
-
Bhala N, Angulo P, van der Poorten D, et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study. Hepatology. 2011;54:1208–16.
-
(2011)
Hepatology
, vol.54
, pp. 1208-1216
-
-
Bhala, N.1
Angulo, P.2
van der Poorten, D.3
-
8
-
-
77950858243
-
Pathology of nonalcoholic fatty liver disease
-
PID: 20195271
-
Brunt EM. Pathology of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2010;7:195–203.
-
(2010)
Nat Rev Gastroenterol Hepatol.
, vol.7
, pp. 195-203
-
-
Brunt, E.M.1
-
9
-
-
0036812716
-
Motion—all patients with NASH need to have a liver biopsy: arguments against the motion
-
PID: 12420035
-
Laurin J. Motion—all patients with NASH need to have a liver biopsy: arguments against the motion. Can J Gastroenterol. 2002;16:722–6.
-
(2002)
Can J Gastroenterol.
, vol.16
, pp. 722-726
-
-
Laurin, J.1
-
10
-
-
84892881288
-
Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
-
PID: 24574716
-
Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20:475–85.
-
(2014)
World J Gastroenterol
, vol.20
, pp. 475-485
-
-
Sumida, Y.1
Nakajima, A.2
Itoh, Y.3
-
11
-
-
0033849619
-
Practices of liver biopsy in France: results of a prospective nationwide survey
-
COI: 1:STN:280:DC%2BD3cvislylsg%3D%3D, PID: 10960438
-
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. Hepatology. 2000;32:477–81.
-
(2000)
Hepatology
, vol.32
, pp. 477-481
-
-
Cadranel, J.F.1
Rufat, P.2
Degos, F.3
-
12
-
-
20444443042
-
Sampling variability of liver biopsy in nonalcoholic fatty liver disease
-
PID: 15940625
-
Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898–906.
-
(2005)
Gastroenterology
, vol.128
, pp. 1898-1906
-
-
Ratziu, V.1
Charlotte, F.2
Heurtier, A.3
-
13
-
-
0031844760
-
Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations
-
COI: 1:STN:280:DyaK1czgvFyjuw%3D%3D, PID: 9647594
-
Younossi ZM, Gramlich T, Liu YC, et al. Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations. Mod Pathol. 1998;11:560–5.
-
(1998)
Mod Pathol
, vol.11
, pp. 560-565
-
-
Younossi, Z.M.1
Gramlich, T.2
Liu, Y.C.3
-
14
-
-
20044374023
-
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
-
PID: 15915461
-
Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–21.
-
(2005)
Hepatology
, vol.41
, pp. 1313-1321
-
-
Kleiner, D.E.1
Brunt, E.M.2
Van Natta, M.3
-
15
-
-
29144492550
-
Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis
-
PID: 16890173
-
Fukusato T, Fukushima J, Shiga J, et al. Interobserver variation in the histopathological assessment of nonalcoholic steatohepatitis. Hepatol Res. 2005;33:122–7.
-
(2005)
Hepatol Res.
, vol.33
, pp. 122-127
-
-
Fukusato, T.1
Fukushima, J.2
Shiga, J.3
-
16
-
-
36749082442
-
Laparoscopic features and interobserver variation of histological diagnosis in patients with non-alcoholic fatty liver disease
-
Miyaoka H, Michitaka K, Tokumoto Y, et al. Laparoscopic features and interobserver variation of histological diagnosis in patients with non-alcoholic fatty liver disease. Dig Endosc. 2008;20:22–8.
-
(2008)
Dig Endosc.
, vol.20
, pp. 22-28
-
-
Miyaoka, H.1
Michitaka, K.2
Tokumoto, Y.3
-
17
-
-
78751575786
-
Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology
-
Gawrieh S, Knoedler DM, Saeian K, et al. Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology. Ann Diagon Pathol. 2011;15:19–24.
-
(2011)
Ann Diagon Pathol.
, vol.15
, pp. 19-24
-
-
Gawrieh, S.1
Knoedler, D.M.2
Saeian, K.3
-
18
-
-
22844448952
-
Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BD2MXpsVantrs%3D, PID: 15998429
-
Suzuki A, Angulo P, Lymp J, et al. Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease. Liver Int. 2005;25:779–86.
-
(2005)
Liver Int
, vol.25
, pp. 779-786
-
-
Suzuki, A.1
Angulo, P.2
Lymp, J.3
-
19
-
-
34447519882
-
Type IV collagen 7 s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage
-
COI: 1:CAS:528:DC%2BD2sXlslOgs7g%3D, PID: 17530362
-
Yoneda M, Mawatari H, Fujita K, et al. Type IV collagen 7 s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage. J Gastroenterol. 2007;42:375–81.
-
(2007)
J Gastroenterol
, vol.42
, pp. 375-381
-
-
Yoneda, M.1
Mawatari, H.2
Fujita, K.3
-
20
-
-
34547483053
-
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest
-
COI: 1:CAS:528:DC%2BD2sXosVyltrg%3D, PID: 17567829
-
Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32–6.
-
(2007)
Hepatology
, vol.46
, pp. 32-36
-
-
Vallet-Pichard, A.1
Mallet, V.2
Nalpas, B.3
-
21
-
-
34247384560
-
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD
-
COI: 1:CAS:528:DC%2BD2sXltlWis7k%3D, PID: 17393509
-
Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846–54.
-
(2007)
Hepatology
, vol.45
, pp. 846-854
-
-
Angulo, P.1
Hui, J.M.2
Marchesini, G.3
-
22
-
-
52649112178
-
Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
-
COI: 1:STN:280:DC%2BD1crpvF2isA%3D%3D, PID: 18390575
-
Harrison SA, Oliver D, Arnold HL, et al. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008;57:1441–7.
-
(2008)
Gut
, vol.57
, pp. 1441-1447
-
-
Harrison, S.A.1
Oliver, D.2
Arnold, H.L.3
-
23
-
-
39549118158
-
Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers
-
PID: 18038452
-
Guha IN, Parkes J, Roderick P, et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: validating the European Liver Fibrosis Panel and exploring simple markers. Hepatology. 2008;47:455–60.
-
(2008)
Hepatology
, vol.47
, pp. 455-460
-
-
Guha, I.N.1
Parkes, J.2
Roderick, P.3
-
24
-
-
75449091784
-
Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
-
COI: 1:CAS:528:DC%2BC3cXisVGgurk%3D, PID: 20101745
-
Wong VW, Vergniol J, Wong GL, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51:454–62.
-
(2010)
Hepatology
, vol.51
, pp. 454-462
-
-
Wong, V.W.1
Vergniol, J.2
Wong, G.L.3
-
25
-
-
77955147344
-
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography
-
PID: 20529989
-
Yoneda M, Suzuki K, Kato S, et al. Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography. Radiology. 2010;256:640–7.
-
(2010)
Radiology
, vol.256
, pp. 640-647
-
-
Yoneda, M.1
Suzuki, K.2
Kato, S.3
-
26
-
-
84867220096
-
Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases
-
PID: 22488593
-
Ochi H, Hirooka M, Koizumi Y, et al. Real-time tissue elastography for evaluation of hepatic fibrosis and portal hypertension in nonalcoholic fatty liver diseases. Hepatology. 2012;56:1271–8.
-
(2012)
Hepatology
, vol.56
, pp. 1271-1278
-
-
Ochi, H.1
Hirooka, M.2
Koizumi, Y.3
-
27
-
-
84872716915
-
A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis
-
PID: 23323209
-
Kuno A, Ikehara Y, Tanaka Y, et al. A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Sci Rep. 2013;3:1065.
-
(2013)
Sci Rep.
, vol.3
, pp. 1065
-
-
Kuno, A.1
Ikehara, Y.2
Tanaka, Y.3
-
28
-
-
84885920606
-
Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling
-
Kuno A, Sato T, Shimazaki H, et al. Reconstruction of a robust glycodiagnostic agent supported by multiple lectin-assisted glycan profiling. Proteomics Clin Appl. 2013. doi:10.1002/prca.201300010.
-
(2013)
Proteomics Clin Appl
-
-
Kuno, A.1
Sato, T.2
Shimazaki, H.3
-
29
-
-
84864826381
-
LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients
-
COI: 1:CAS:528:DC%2BC38XhsVKmur7N, PID: 22535703
-
Ito K, Kuno A, Ikehara Y, et al. LecT-Hepa, a glyco-marker derived from multiple lectins, as a predictor of liver fibrosis in chronic hepatitis C patients. Hepatology. 2012;56:1448–56.
-
(2012)
Hepatology
, vol.56
, pp. 1448-1456
-
-
Ito, K.1
Kuno, A.2
Ikehara, Y.3
-
31
-
-
84927668697
-
-
Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 12 Jul 2014. doi:. (Epub ahead of print)
-
Yamasaki K, Tateyama M, Abiru S, et al. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology. 12 Jul 2014. doi: 10.1002/hep.27305. (Epub ahead of print).
-
-
-
-
32
-
-
0033200054
-
Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions
-
COI: 1:STN:280:DyaK1MvhtFyisw%3D%3D, PID: 10484010
-
Brunt EM, Janney CG, Di Bisceglie AM, et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94:2467–74.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 2467-2474
-
-
Brunt, E.M.1
Janney, C.G.2
Di Bisceglie, A.M.3
-
33
-
-
0042265556
-
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C
-
PID: 12883497
-
Wai CT, Greenson JK, Fontana RJ, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38:518–26.
-
(2003)
Hepatology
, vol.38
, pp. 518-526
-
-
Wai, C.T.1
Greenson, J.K.2
Fontana, R.J.3
-
34
-
-
0022548130
-
Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer
-
COI: 1:CAS:528:DyaL28XksVSlur4%3D, PID: 3516389
-
Iacobelli S, Arnò E, D’Orazio A, et al. Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res. 1986;46:3005–10.
-
(1986)
Cancer Res
, vol.46
, pp. 3005-3010
-
-
Iacobelli, S.1
Arnò, E.2
D’Orazio, A.3
-
35
-
-
0030221401
-
Elevated serum levels of 90 K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients
-
COI: 1:STN:280:DyaK2s%2FjtlSgtQ%3D%3D, PID: 8878784
-
Artini M, Natoli C, Tinari N, et al. Elevated serum levels of 90 K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol. 1996;25:212–7.
-
(1996)
J Hepatol
, vol.25
, pp. 212-217
-
-
Artini, M.1
Natoli, C.2
Tinari, N.3
-
36
-
-
0029759376
-
Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion
-
COI: 1:CAS:528:DyaK28XmtVyltbk%3D, PID: 8813152
-
Inohara H, Akahani S, Koths K, et al. Interactions between galectin-3 and Mac-2 binding protein mediate cell-cell adhesion. Cancer Res. 1996;56:4530–4.
-
(1996)
Cancer Res
, vol.56
, pp. 4530-4534
-
-
Inohara, H.1
Akahani, S.2
Koths, K.3
-
37
-
-
0032536822
-
Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin
-
COI: 1:CAS:528:DyaK1cXit1Gitr0%3D, PID: 9501082
-
Sasaki T, Brakebusch C, Engel J, et al. Mac-2 binding protein is a cell-adhesive protein of the extracellular matrix which self-assembles into ring-like structures and binds beta1 integrins, collagens and fibronectin. EMBO J. 1998;17:1606–13.
-
(1998)
EMBO J
, vol.17
, pp. 1606-1613
-
-
Sasaki, T.1
Brakebusch, C.2
Engel, J.3
Timpl, R.4
-
38
-
-
65449190146
-
The HCV serum proteome: a search for fibrosis protein markers
-
COI: 1:STN:280:DC%2BD1MzlvFylug%3D%3D, PID: 19226329
-
Cheung KJ, Tilleman K, Deforce D, et al. The HCV serum proteome: a search for fibrosis protein markers. J Viral Hepat. 2009;16:418–29.
-
(2009)
J Viral Hepat.
, vol.16
, pp. 418-429
-
-
Cheung, K.J.1
Tilleman, K.2
Deforce, D.3
-
39
-
-
84885947103
-
-
Kamada Y, Fujii H, Fujii H, et al. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. Proteomics Clin Appl. 14 June 2013. doi:. (Epub ahead of print)
-
Kamada Y, Fujii H, Fujii H, et al. Serum Mac-2 binding protein levels as a novel diagnostic biomarker for prediction of disease severity and nonalcoholic steatohepatitis. Proteomics Clin Appl. 14 June 2013. doi: 10.1002/prca.201200137. (Epub ahead of print).
-
-
-
-
40
-
-
84855390033
-
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population
-
COI: 1:CAS:528:DC%2BC38XivVWit7s%3D, PID: 22221544
-
Sumida Y, Yoneda M, Hyogo H, et al. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 2012;12:2.
-
(2012)
BMC Gastroenterol.
, vol.12
, pp. 2
-
-
Sumida, Y.1
Yoneda, M.2
Hyogo, H.3
-
41
-
-
50649109837
-
Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis
-
PID: 18616651
-
Wong VW, Wong GL, Chim AM, et al. Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. Am J Gastroenterol. 2008;103:1682–8.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1682-1688
-
-
Wong, V.W.1
Wong, G.L.2
Chim, A.M.3
|